Jay Venkatesan, See Remarks at Angion Biomedica Corp. (ANGN), bought 554,488 shares at $2.55 ($1.5M) on 2021-12-27, disclosed to the SEC on 2021-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 66,907 | $171K | 11.7% |
| 2 | $2.55 | 66,907 | $171K | 11.7% |
| 3 | $2.66 | 210,337 | $559K | 38.3% |
| 4 | $2.66 | 210,337 | $559K | 38.3% |
| Total | $2.63 avg | 554,488 | $1.5M | 100% |
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |
| ANGN | BUY | 2021-12-20 | $177K | — | Filing → |